KIDS
Orthopediatrics Corp
22.20$
+2.2%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 22.6% | 29.0% | 28.0% | 22.7% | 26.6% | 32.5% | 27.0% | 27.9% | 26.1% | 26.8% | 26.9% | 25.7% | 26.3% | |
| 77.4% | 71.0% | 72.0% | 77.3% | 73.4% | 67.5% | 73.0% | 72.1% | 73.9% | 73.2% | 73.1% | 74.3% | 73.7% | |
| 6.4% | 7.3% | 6.7% | 4.8% | 4.7% | 5.5% | 4.5% | 3.5% | 3.8% | 3.7% | 3.8% | 3.3% | 3.6% | |
| 45.0% | 52.1% | 55.3% | 51.8% | 48.2% | 46.4% | 57.8% | 49.8% | 47.6% | 48.6% | 52.3% | 46.5% | 48.6% | |
| 88.7% | 92.5% | 93.8% | 88.0% | 83.6% | 94.2% | 93.9% | 89.5% | 81.9% | 82.2% | 87.1% | 80.0% | 82.7% | |
| -11.3% | -21.4% | -21.8% | -10.7% | -10.2% | -26.7% | -21.0% | -17.4% | -7.9% | -8.9% | -14.0% | -5.8% | -9.0% | |
| 0.1% | 0.8% | 1.4% | 0.5% | 0.7% | 2.5% | 2.1% | 1.8% | 3.0% | 3.1% | 3.5% | 3.6% | 3.3% | |
| -9.4% | -18.4% | -23.1% | -11.5% | -16.7% | -31.2% | -20.0% | -11.6% | -19.4% | -15.8% | -18.3% | -9.8% | -15.6% | |
| 2.1% | -0.6% | -5.7% | 0.0% | -2.2% | -0.6% | 0.4% | 0.1% | -0.2% | 0.6% | -0.3% | 0.3% | 0.1% | |
| -11.5% | -17.8% | -17.5% | -11.4% | -14.5% | -30.5% | -20.3% | -11.6% | -19.2% | -16.4% | -18.0% | -10.2% | -15.7% | |
| 1.4% | -16.7% | -10.5% | -1.9% | -6.3% | -8.7% | -8.2% | -1.3% | -7.8% | 3.2% | -5.1% | -6.2% | -4.1% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.